Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

The purpose of the protocol is to describe the proportion of subjects treated continuously with triptorelin during 12 months following treatment initiation. This study will take place at 187 locations (approximately) in France.

Inclusion Criteria:

• At least 18 years old
• Histologically confirmed prostate cancer
• Triptorelin to be initiated in its labelled indication for a planned total duration of at least 12 months; decision to start triptorelin was made voluntarily by the physician as part of routine medical practice, prior to the inclusion in the study
• Ability to understand and complete questionnaire,

Exclusion Criteria:

• Previously received a hormonal therapy during the last 6 months before inclusion,
• Simultaneously participates in a clinical trial.